Explore Biotech Companies

ExcepGen is an early-stage biotech company developing an RNA therapeutics platform to create more tolerable RNA medicines and vaccines.

📍 San Francisco, CA

Endogena Therapeutics is a clinical-stage biotech company developing endogenous regenerative medicines to repair tissues damaged by aging.

📍 San Francisco, CA

Element Science develops wearable devices to prevent sudden cardiac death, creating lifesaving solutions for high-risk individuals.

📍 San Francisco, CA

Dispatch Bio develops novel immuno-oncology treatments for solid tumors, aiming for a universal approach to cure cancer.

📍 Philadelphia, PA

Delve Bio is a biotech company using metagenomic NGS diagnostics to revolutionize infectious disease testing and empower clinicians with rapid, accurate pathogen identification.

📍 San Francisco, CA

Oral small molecule discovery using AI and cryo-EM for high-value targets. Partners with Novo Nordisk for cardiometabolic diseases.

📍 San Francisco, CA

Deciduous Therapeutics develops novel immune-therapies to eliminate senescent cells and treat age-related diseases by activating the body's natural immune mechanisms.

📍 San Francisco, CA

Concentric Analgesics is a biotech company discovering and developing novel, non-opioid therapeutics for pain management, focusing on single local administration for long-lasting relief.

📍 San Francisco, CA

Compugen is a clinical-stage drug discovery and development company utilizing a predictive computational platform for novel biologics, particularly in cancer immunotherapy.

📍 San Francisco, CA

Coherence Neuro develops AI-driven therapeutic neurotechnology and brain-computer interfaces for real-time cancer monitoring and treatment.

📍 San Francisco, CA

CloudCath provides a remote monitoring platform for catheter-based treatments, focusing on proactive detection of infections in peritoneal dialysis patients.

📍 San Francisco, CA

Chai Discovery is an AI drug discovery company using frontier AI to predict and reprogram biochemical interactions for new therapies.

📍 San Francisco, CA

Cairn Biosciences uses live cell assays and its COMPASS platform to discover new medicines for neurodegenerative diseases and brain injuries.

📍 San Francisco, CA

Braveheart Bio is a late clinical-stage biotech company developing precision small-molecule therapeutics for hypertrophic cardiomyopathy and related cardiovascular conditions.

📍 San Francisco, CA

BioQ Pharma develops ready-to-use infusible drug delivery systems for the pharmaceutical market.

📍 San Francisco, CA

Benchling provides a cloud-based, biology-first software platform for biotech and pharmaceutical R&D, unifying scientific data and collaboration.

📍 San Francisco, CA

Apellis Pharmaceuticals is a biopharma company pioneering C3 therapies to treat debilitating diseases, including rare kidney and eye conditions.

📍 Waltham, MA

Amber Bio pioneers new gene editing modalities using multi-kilobase RNA writing for previously undruggable diseases.

📍 San Francisco, CA

AltruBio is a clinical-stage biotech company developing novel antibody therapeutics for immunological and inflammatory diseases, including ulcerative colitis.

📍 San Francisco, CA

Alife Health uses AI to improve IVF outcomes, streamline clinic operations, and personalize fertility care with tools like embryo grading and scheduling.

📍 San Francisco, CA

Aizon provides an AI software platform for GxP compliant pharma manufacturing, revolutionizing batch processing and optimizing yield.

📍 San Francisco, CA

Aelan Cell Technologies researches and commercializes innovative stem cell technologies for new biomedical treatments and diagnostics.

📍 San Francisco, CA

Achira builds atomistic foundation simulation models using AI and physics for accelerated drug discovery.

📍 San Francisco, CA

89bio is a clinical-stage biopharma company developing liver and cardiometabolic disease therapies, acquired by Roche.

📍 San Francisco, CA